{"summary":"Methodical professional with robust experience in analytical and formulation development with focus on execution of GMP manufacturing. Diligently directed drug product development processes, showcasing critical strategic planning prowess. Highly effective in advancing product pipelines from pre-clinical through pre-commercial readiness. Acclaimed for robust expertise in overseeing manufacturing activities, ensuring compliance with stringent industry and regulatory standards.","lastName":"Knihtila","objectUrn":"urn:li:member:217916136","geoRegion":"Boston, Massachusetts, United States","fullName":"Ryan Knihtila","firstName":"Ryan","currentPositions":[{"companyName":"Tectonic Therapeutic, Inc.","description":"Served as technical lead for external drug product and analytical development workflows, including the development of a stable, high-concentration liquid formulation for subcutaneous administration of a complex biologic.\n\nLed preparation and execution of GMP manufacturing of GMP DP for FIH trials.\n\nManaged the development and qualification of analytical release assays, including separation methods and bioassay.\n\nCoordinated efforts for authoring Module 3 for IMPD\/IND for the lead program.\n\nLed a team of four scientists overseeing the expression, purification, and characterization of hits\/leads from discovery workflows through clinical development and manufacturing.\n\nDeveloped manufacturability workflows, identifying liabilities for candidate molecules, and optimizing formulation development processes to accelerate CMC timelines.\n\nEstablished pre-IND workflows bolstering protein science team operations.\n\nDrove analytical and formulation development studies alongside a CDMO for lead assets.\n\nForecasted future needs for drug product life cycle, including CIU and PFS studies.\n\nIntegrated pioneering technology for biophysical and analytical characterization of biologics.\n\nImplemented workflows for stable CHO production and purification for DC-enabling studies.","title":"Director","companyUrnResolutionResult":{"employeeCountRange":"11-50","headquarters":{"geographicArea":"Massachusetts","country":"United States","city":"Watertown","postalCode":"02472","line2":"Suite 210","line1":"490 Arsenal Way"},"website":"http:\/\/www.tectonictx.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/tectonictx\/","industry":"Biotechnology"},"companyUrn":"urn:li:fs_salesCompany:28502924","tenureAtCompany":{"numYears":2,"numMonths":10},"startedOn":{"month":1,"year":2023}}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAAz9IugBrJbDKvKGhruXIIal2_3sR2TOaus,NAME_SEARCH,FmoJ)","projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":2016},"degree":"Doctor of Philosophy (Ph.D.)","eduId":135080355,"schoolUrn":"urn:li:fs_salesSchool:5274","school":"urn:li:fs_salesSchool:5274","fieldsOfStudy":["Chemistry and Chemical Biology"],"schoolName":"Northeastern University","startedOn":{"year":2011}},{"endedOn":{"year":2010},"degree":"Bachelor of Science","eduId":136175461,"schoolUrn":"urn:li:fs_salesSchool:26285","school":"urn:li:fs_salesSchool:26285","fieldsOfStudy":["Chemistry"],"schoolName":"Worcester State College","startedOn":{"year":2007}}],"skills":[{"numOfEndorsement":0,"name":"Formulation"},{"numOfEndorsement":0,"name":"Analytical Chemistry"},{"numOfEndorsement":3,"name":"Protein Chemistry"},{"numOfEndorsement":0,"name":"Biopharmaceuticals"},{"numOfEndorsement":0,"name":"High-Performance Liquid Chromatography (HPLC)"},{"numOfEndorsement":0,"name":"Biotechnology"},{"numOfEndorsement":1,"name":"Assay Development"},{"numOfEndorsement":0,"name":"Manufacturing"},{"numOfEndorsement":0,"name":"Project Management"},{"numOfEndorsement":0,"name":"Writing"},{"numOfEndorsement":4,"name":"Chemistry"},{"numOfEndorsement":4,"name":"Biochemistry"},{"numOfEndorsement":0,"name":"Protein Expression"},{"numOfEndorsement":4,"name":"Protein Purification"},{"numOfEndorsement":0,"name":"Statistical Data Analysis"},{"numOfEndorsement":0,"name":"Mentoring"},{"numOfEndorsement":0,"name":"Teaching"},{"numOfEndorsement":0,"name":"People Management"},{"numOfEndorsement":0,"name":"Presentation Skills"},{"numOfEndorsement":4,"name":"X-ray crystallography"},{"numOfEndorsement":0,"name":"Fast Protein Liquid Chromatography (FPLC)"},{"numOfEndorsement":0,"name":"Plasmid Construction"},{"numOfEndorsement":0,"name":"Regulatory Documentation"},{"numOfEndorsement":0,"name":"CMC"},{"numOfEndorsement":0,"name":"CMC development"},{"numOfEndorsement":0,"name":"Enzymology"},{"numOfEndorsement":0,"name":"Neutron Crystallography"},{"numOfEndorsement":0,"name":"Drug Substance"},{"numOfEndorsement":0,"name":"Drug Product"},{"numOfEndorsement":0,"name":"Lyophilization"},{"numOfEndorsement":0,"name":"QAQC"},{"numOfEndorsement":0,"name":"IND"},{"numOfEndorsement":0,"name":"Capillary Electrophoresis"},{"numOfEndorsement":0,"name":"iCIEF"},{"numOfEndorsement":0,"name":"CE-SDS"},{"numOfEndorsement":0,"name":"Empower"},{"numOfEndorsement":0,"name":"Subvisible Particle Analysis"},{"numOfEndorsement":0,"name":"Dynamic Light Scattering (DLS)"},{"numOfEndorsement":0,"name":"CDMO"}],"numOfConnections":362,"patents":[],"headline":"Director","courses":[],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/ryan-knihtila","organizations":[],"location":"Boston, Massachusetts, United States","publications":[{"name":"Neutron Crystal Structure of RAS GTPase puts in question the Protonation State of the GTP \u03b3-Phosphate","publishedOn":{"month":10,"day":29,"year":2015},"publisher":"Journal of Biological Chemistry","url":"http:\/\/www.jbc.org\/content\/early\/2015\/10\/29\/jbc.M115.679860.abstract","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAz9IugBrJbDKvKGhruXIIal2_3sR2TOaus,NAME_SEARCH,FmoJ)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAACO4ZoBKNWSPzC0orowYdcIHnsIAeKulrM,NAME_SEARCH,X1zX)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAVTSF8B6F5ugMSRQ194WFH_M7Yg_RQPmV4,NAME_SEARCH,EEHY)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAmIqZ4BKchCN3tiYTv0Qll92HT5X7IZ69M,NAME_SEARCH,tAER)"}]},{"name":"Neutron Crystal Structure of Ras GTPase sets New Paradigm for GTP Hydrolysis","publishedOn":{"year":2015},"publisher":"The FASEB Journal","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAz9IugBrJbDKvKGhruXIIal2_3sR2TOaus,NAME_SEARCH,FmoJ)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAACO4ZoBKNWSPzC0orowYdcIHnsIAeKulrM,NAME_SEARCH,X1zX)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAVTSF8B6F5ugMSRQ194WFH_M7Yg_RQPmV4,NAME_SEARCH,EEHY)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAmIqZ4BKchCN3tiYTv0Qll92HT5X7IZ69M,NAME_SEARCH,tAER)"}]}],"positions":null,"posts":[{"createdAt":1716217980000,"insightId":"4c06f504-6ca4-45aa-9c2c-b69d12e616c8","activityUnion":{"postActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D4D22AQHB4rkcoi8Ajw\/feedshare-shrink_2048_1536\/0\/1716218028630?e=1720051200&v=beta&t=wG1hGV-jvgQoyGHg-npMUu486A_onkaoIplzRyTb9L0"}},"socialMetadata":{"reactionTypeCounts":[{"type":"PRAISE","count":13},{"type":"APPRECIATION","count":1},{"type":"LIKE","count":61},{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7198340150316167168","threadUrn":"urn:li:activity:7198340150316167168","reactionsCount":76,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7198340147594047488","message":{"attributes":[{"start":347,"length":9,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:asco2024"}}},{"start":357,"length":9,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:oncology"}}},{"start":367,"length":16,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:drugdevelopment"}}},{"start":384,"length":12,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:patientcare"}}},{"start":397,"length":12,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:astrazeneca"}}},{"start":411,"length":13,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:727534"}}},{"start":425,"length":16,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:187184175"}}},{"start":442,"length":9,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:9678527"}}},{"start":452,"length":11,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:4301630"}}},{"start":464,"length":13,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:6309063"}}},{"start":478,"length":13,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:333411506"}}}],"text":"ASCO2024 is almost here and I'm privileged to have the opportunity to engage with the oncology community and share our dedication to innovative drug development and our commitment to making a difference for patients seeking new treatment options. If you're interested in learning more, please connect with me and let's arrange to meet in Chicago. #ASCO2024 #oncology #drugdevelopment #patientcare #AstraZeneca \nEllen Willcox Matthew ODonnell Kate Roye Amy Spencer Jason Hanford Alfie Hammali"},"entityUrn":"urn:li:share:7198340147594047488"}}},{"createdAt":1709648640000,"insightId":"b79619af-7943-4675-86b8-4883b5a3ceba","activityUnion":{"postActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"image":{"attributes":[{"originalImageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4E27AQGa9_f_VQmm_A\/articleshare-shrink_800\/0\/1712089183509?e=1717977600&v=beta&t=vVE5WUT0YkqkQ2oB8sVe6NTSJcHikd6RCnXwhk2ye-A","sourceType":"URL","imageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4E27AQGa9_f_VQmm_A\/articleshare-shrink_800\/0\/1712089183509?e=1717977600&v=beta&t=vVE5WUT0YkqkQ2oB8sVe6NTSJcHikd6RCnXwhk2ye-A"}]},"description":"Join AstraZeneca's industry-leading talent scouting team as a Global Talent Scout. In this role, you will be responsible for developing mid to senior level external talent pools aligned with our business and talent engagement strategies. You will...","fullText":"Join AstraZeneca's industry-leading talent scouting team as a Global Talent Scout. In this role, you will be responsible for developing mid to senior level external talent pools aligned with our business and talent engagement strategies. You will manage the full recruitment process\u2014from identifying talent needs to hiring\u2014focusing on timely, cost-effective solutions and maintaining requisition targets. This role requires collaboration with various stakeholders and the ability to engage and influence at high organizational levels. Accountabilities: As a Global Talent Scout, you will develop a short to medium-term external talent sourcing strategy (0-18 months) for a business area. You will proactively create and maintain an external talent pool linked to key roles and skills, sharing with business and talent acquisition teams. You will encourage hiring managers to engage with external prospects to strengthen the talent pipeline. You will convert top talent pool candidates into hires, focusing on specialist and leadership roles, to save costs and time. You will also engage in the full recruitment life cycle from marketing to onboarding. Essential Skills\/Experience: - Significant experience in pharma talent acquisition - Talent Acquisition Partnering - Talent Acquisition Expertise - Campaign Planning & Candidate Experience - Impact & Influence - Talent Pipeline Building and Talent Nurturing - Learning Agility Desirable Skills\/Experience: - Business Degree or similar qualification. - Multilingual skills beneficial. - Proficient in digital talent sourcing and management tools. - Knowledgeable about drug development and commercialization. - Talent scouting\/executive search experience is beneficial. - Experienced in using talent scouting techniques for internal talent development. - Has a strong network in Therapy\/Business areas at the Director level and above. - Possesses a deep understanding of the pharmaceutical industry. - Experience in corporate recruiting within Pharma or Biotech sectors. At AstraZeneca, we\u2019re dedicated to being a Great Place to Work. Where you are empowered to push the boundaries of science, challenge convention and unleash your entrepreneurial spirit. We are a global, science-led, patient-focused biopharmaceutical company that focuses on discovering, developing and commercialising prescription medicines for some of the world\u2019s most serious diseases. We are more than one of the world\u2019s leading pharmaceutical companies. We are a high-performing team, united and motivated by our shared purpose \u2013 to push the boundaries of science to deliver life-changing medicines. Are you ready to make a difference in medicine, patients, and society? Are you ready to embrace differences and take bold actions to drive the change needed to meet global healthcare and sustainability challenges? If so, apply today! Date Posted 04-mar-2024 Closing Date 18-mar-2024 AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements. AstraZeneca is an exciting global, innovation-driven biopharmaceutical company. We\u2019re inspired by what science can do. Driven by the desire to meet unmet patient needs in our core therapeutic areas. Bold in our thinking. Proactive in pursuing discoveries beyond imagination. At sites across the world, we bring teams together in a spirit of collaboration to turn great ideas into life-changing medicines \u2013 strengthening our product portfolio and harnessing the potential of a pipeline across all stages of the drug development process. You\u2019ll be part of a team that\u2019s rolling back the frontiers of science to turn yesterday\u2019s impossible into the normal of tomorrow. So, if you share our focus and passion, join us and make a difference to patients \u2013 and in return, we\u2019ll help you develop way beyond what you thought possible.","resolvedUrl":"https:\/\/astrazeneca.wd3.myworkdayjobs.com\/Careers\/job\/Spain---Barcelona\/Global-Talent-Scout_R-193843","title":"Global Talent Scout","sourceDomain":"astrazeneca.wd3.myworkdayjobs.com"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":151},{"type":"PRAISE","count":4},{"type":"EMPATHY","count":4}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7170786255641763840","threadUrn":"urn:li:activity:7170786255641763840","reactionsCount":159,"commentsCount":5,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7170786254379290627","message":{"attributes":[{"start":474,"length":18,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:619187233"}}},{"start":530,"length":24,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/efXMqR4s"}}}],"text":"We're expanding our R&D focused Talent Scout team in Barcelona.  As a Talent Scout, you'll work closely with senior leaders to bring the brightest and best to our team. Join us in our relentless quest to drive innovation and deliver transformative new treatment options to patients who need them. \nIf you have experience proactively building talent pipelines, engaging senior R&D professionals and nurturing relationships, we want to hear from you!  \nConnect with myself or Carlota Sanz P\u00e9rez and follow the link below to apply:\n\nhttps:\/\/lnkd.in\/efXMqR4s "},"entityUrn":"urn:li:share:7170786254379290627"}}},{"createdAt":1715375520000,"insightId":"b77316e6-7d6a-4d4e-b297-b9ea06c11176","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":2}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7194794633103650816,7194806435115859969)","threadUrn":"urn:li:activity:7194794633103650816","reactionsCount":2,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":30,"length":10,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:5945467"}}}],"text":"Good luck in the next chapter Gail Atlas "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7194794633103650816"}}},{"createdAt":1713974400000,"insightId":"134cbc3b-bb98-4f4c-9d24-ba93fdce669e","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7188566333297504256,7188929688189218817)","threadUrn":"urn:li:ugcPost:7188566333297504256","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":61,"length":10,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:536926436"}}}],"text":"We are very pleased to have you join our  Scouting community Todd Mills"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7188566333297504256"}}},{"createdAt":1713559020000,"insightId":"8515840a-b03e-48f7-8abc-7ba121cb8bf4","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":2}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7187106951841882112,7187187484655525888)","threadUrn":"urn:li:activity:7187106951841882112","reactionsCount":2,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":37,"length":16,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:1066149917"}}}],"text":"Amazing, many congratulations to you Jorge Reis-Filho "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7187106951841882112"}}},{"createdAt":1713558960000,"insightId":"c4cc8cb2-cce3-4444-a606-45764789f4c8","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7187007194641375233,7187187254375665664)","threadUrn":"urn:li:activity:7187007194641375233","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":37,"length":11,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:6639840"}}},{"start":54,"length":16,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:13755670"}}}],"text":"Please do connect with my colleagues Beata Klecz  abd Juan Diego Casas  if you are attending ECMID"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7187007194641375233"}}},{"createdAt":1712072940000,"insightId":"391623b7-cc07-4040-92ef-0c3b3afe7398","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":3}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7180938844979003393,7180954416919810048)","threadUrn":"urn:li:activity:7180938844979003393","reactionsCount":3,"commentsCount":1,"canComment":true},"commentary":{"attributes":[{"start":28,"length":11,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:76606172"}}}],"text":"Many congratulations to you Ben Ventham, we're really happy to have you join our Scouting community and LT. "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7180938844979003393"}}},{"createdAt":1710510840000,"insightId":"3d68a72d-55e7-4aae-aae3-1ba4c3f64e6f","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7174330943493607424,7174402687067664384)","threadUrn":"urn:li:ugcPost:7174330943493607424","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":28,"length":6,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:41733349"}}}],"text":"Many congratulations to you Claire"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7174330943493607424"}}},{"createdAt":1710447600000,"insightId":"5dd8d3c6-4da6-4ec1-99cf-ac19439b23ed","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7174109111213527040,7174137362262708224)","threadUrn":"urn:li:activity:7174109111213527040","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":6,"length":5,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:1734737"}}}],"text":"Bravo Renee, love this and could not agree more"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7174109111213527040"}}},{"createdAt":1709894820000,"insightId":"71ad2064-5936-48ae-85cd-e78671814fab","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7171797928359968768,7171818683965526016)","threadUrn":"urn:li:activity:7171797928359968768","reactionsCount":1,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"Exactly - not just one day a year! Hope all well with you?"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7171797928359968768"}}}]}